Literature DB >> 2506994

New drugs for systemic fungal infections.

D W Denning1, D A Stevens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2506994      PMCID： PMC1837293          DOI： 10.1136/bmj.299.6696.407

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

2.  Experience with itraconazole in cryptococcosis and aspergillosis.

Authors:  M A Viviani; A M Tortorano; M Langer; M Almaviva; C Negri; S Cristina; S Scoccia; R De Maria; R Fiocchi; P Ferrazzi
Journal:  J Infect       Date:  1989-03       Impact factor: 6.072

3.  Cryptococcosis in the acquired immunodeficiency syndrome.

Authors:  J A Kovacs; A A Kovacs; M Polis; W C Wright; V J Gill; C U Tuazon; E P Gelmann; H C Lane; R Longfield; G Overturf
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

4.  Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment.

Authors:  A Zuger; E Louie; R S Holzman; M S Simberkoff; J J Rahal
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

5.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

Authors:  W E Dismukes; G Cloud; H A Gallis; T M Kerkering; G Medoff; P C Craven; L G Kaplowitz; J F Fisher; C R Gregg; C A Bowles; S Shadomy; A M Stamm; R B Diasio; L Kaufman; S Soong; W C Blackwelder
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

6.  Treatment of mycoses with itraconazole.

Authors:  R M Tucker; P L Williams; E G Arathoon; D A Stevens
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691
  6 in total
  3 in total

1.  10 year review of invasive aspergillosis detected at necropsy.

Authors:  A P Boon; D O'Brien; D H Adams
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

Review 2.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

3.  Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.

Authors:  A Gil; P Lavilla; E Valencia; V Pintado; M L Dupla; M A Khamashta; J García-Puig; J Ortiz-Vázquez
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.